Vlad Razumovich

Co-Founder, QI Supplements.

Federal Way, Washington. In this industry since 2015.

I am one of a very small number of people in the West with direct sourcing relationships inside the original Khavinson peptide bioregulator manufacturer network in Europe. I did not find those relationships through a trade directory. I built them over years. They are the reason QI Supplements exists and the reason every product we carry can be traced back to its source.

Since founding QI Supplements in 2015, I have personally guided more than 20,000 customers through peptide bioregulator protocols. That means real conversations about which peptides target which organ systems, how to cycle them, how to stack them, and what the underlying Russian clinical research actually supports versus what gets misrepresented in this market. Most people who come to QI are starting from zero. I meet them there.

I am currently the Chairman Of The Board For QI Supplements.

Why I Started Using These Protocols

I did not come to peptide bioregulators through research alone. I came to them through necessity.

I was in a serious car accident. Firefighters cut the other driver out of the wreckage. I could not move my shoulder. I had little feeling in my left hand. I went straight into emergency surgery with torn tendons and a real possibility of permanent loss of function.

The standard medical path was narcotics and a long, uncertain rehab. I refused to accept that as the only option.

Within 48 hours of surgery I had built a protocol. Cartilage peptides. Blood vessel peptides. Muscle peptides. Central nervous system support. Three weeks on, three weeks off, because peptides are built to restore, not mask. The injury also triggered a serious bout of depression and anxiety from the neurochemical disruption. I added brain support protocols and worked through that alongside the physical recovery.

I was out of my sling and into rehab ahead of schedule.

That experience is what made me certain these protocols work. Not because I read about them. Because I used them on myself when I had everything to lose and watched what happened. I have been using peptide bioregulator protocols personally ever since.

The Research Behind the Protocols I Recommend

Peptide bioregulators were developed by Dr. Vladimir Khavinson beginning in the 1970s at the Military Medical Academy in Leningrad, continued at the St. Petersburg Institute of Bioregulation and Gerontology. The research began as a classified Soviet military project. After the collapse of the USSR, Khavinson transferred the technology to civil manufacturers in Europe.

Khavinson's body of work spans more than 775 scientific papers and 196 patents. His foundational 2002 review, Peptides and Ageing, published in Neuro Endocrinology Letters, summarized three decades of research on tissue-specific geroprotective effects in animals and humans. [1]

The strongest human clinical data comes from a randomized controlled trial by Khavinson and Morozov published in 2003. The study followed 266 elderly patients over 6 to 8 years. Patients treated with Thymalin and Epithalamin combined showed a 4.1-fold reduction in mortality compared to the control group. [2]

Work published in Biochemistry (Moscow) in 2015 established the epigenetic mechanism behind these results: the peptides alter DNA methylation patterns in aging cells, tissue-specifically activating genes involved in repair and regeneration. [3]

When I recommend a protocol, it is grounded in this research. Not in marketing copy.

Background and Credentials

I co-founded QI Supplements in 2015 as QI Enterprise, Inc., a Washington State corporation based in Federal Way. I have been the primary protocol consultant since founding.

I hold a Bachelor's degree in engineering and I am a certified Project Management Professional (PMP), a credential that requires demonstrated experience managing complex technical projects and passing a rigorous examination. I have applied that same systems thinking to everything I do at QI Supplements. Building direct sourcing relationships with European manufacturers. Designing multi-phase protocols for clients. Managing a product catalog that requires precise quality control across an international supply chain. Analytical discipline built in engineering and project management does not leave when you change industries.

Outside of QI Supplements, I am the founder of Gutentight Racing, a Pacific Northwest Mazda Miata parts business based at the same Federal Way address. I race as car number 079 in the Lucky Dog Racing League and serve as a Team Captain for the Gutentight Racing team. I put my name on everything I do.

What I Write About

Every article on the QI Supplements blog is written by me or reviewed by me before publication. I write about what the Khavinson research actually says, how to build protocols for specific organ systems, what the cycling and stacking evidence supports, and what separates authentic bioregulators from the growing number of imitations in this market.

I do not make disease claims. I do not write copy that implies these supplements diagnose, treat, cure, or prevent any disease. That is not legal for dietary supplements and it is not honest. Every article follows DSHEA structure/function standards.

If you have a question about a specific protocol, you can reach me directly at 1-800-765-7493 or through the Advanced Wellness Program.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Content on this page is for educational purposes only and does not substitute for professional medical advice.

References

Khavinson VKh. Peptides and Ageing. Neuro Endocrinology Letters. 2002;23 Suppl 3:11-144. PubMed: 12374906
Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinology Letters. 2003;24(3-4):233-40. PubMed: 14523363
Ashapkin VV, Linkova NS, Khavinson VKh, Vanyushin BF. Epigenetic mechanisms of peptidergic regulation of gene expression during aging of human cells. Biochemistry (Moscow). 2015;80(3):310-22. DOI: 10.1134/S0006297915030062